Wells Fargo & Company Increases Mettler-Toledo International (NYSE:MTD) Price Target to $1,400.00

Mettler-Toledo International (NYSE:MTD) had its price target upped by equities researchers at Wells Fargo & Company from $1,350.00 to $1,400.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 5.17% from the stock’s previous close.

A number of other analysts have also recently weighed in on the company. Stifel Nicolaus reduced their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Wolfe Research began coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating for the company. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Robert W. Baird boosted their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday. Finally, Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their target price for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $1,368.00.

Mettler-Toledo International Stock Down 0.7 %

MTD stock opened at $1,331.19 on Monday. The firm’s 50-day simple moving average is $1,280.49 and its 200 day simple moving average is $1,342.46. The stock has a market cap of $28.09 billion, a PE ratio of 32.84, a price-to-earnings-growth ratio of 4.80 and a beta of 1.13. Mettler-Toledo International has a fifty-two week low of $1,133.46 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 564.51%. Equities analysts forecast that Mettler-Toledo International will post 41.94 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now owns 6 shares in the company, valued at $7,524.54. This trade represents a 95.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.94% of the stock is owned by company insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors have recently modified their holdings of the business. DT Investment Partners LLC raised its stake in shares of Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock valued at $102,000 after acquiring an additional 8 shares during the last quarter. Farther Finance Advisors LLC lifted its position in Mettler-Toledo International by 14.3% in the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 8 shares in the last quarter. Bleakley Financial Group LLC boosted its position in shares of Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock valued at $1,135,000 after buying an additional 9 shares during the last quarter. Suncoast Equity Management boosted its holdings in Mettler-Toledo International by 2.0% during the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after acquiring an additional 9 shares during the last quarter. Finally, Huntington National Bank grew its position in Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after purchasing an additional 9 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.